1 / 28

Dementias

Dementias. Neurodegenerative Disorders. A varied assortment of central nervous system disorders characterized by gradual and progressive loss of neural tissue. Examples: Alzheimer’s, Parkinson’s, Multiple Sclerosis, dementia with Lewy bodies, multiple system atrophy

dinh
Download Presentation

Dementias

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dementias Dementias

  2. Neurodegenerative Disorders • A varied assortment of central nervous system disorders characterized by gradual and progressive loss of neural tissue. • Examples: Alzheimer’s, Parkinson’s, Multiple Sclerosis, dementia with Lewy bodies, multiple system atrophy • Disorders can affect anyone at any age, not just a disease in the elderly • Can even strike during infancy Dementias

  3. Incidence, Prevalence • Usually a disease of aging populations • Highest prevalence over age 85. • Can occur in children and adolescents, and shown as a deterioration in function. • Estimates (Census, 2001) • 3% in adults 20-70 • 10% 70-85 • 20% over 85 years • 10% genetic concordance (Sherrington, 1995) Dementias

  4. Prevalence • Parkinson’s: 8-15 in 100,000 (0.00008-0.00015%) • Alzheimer’s: 435,000 persons over 65 years (0.01%) Dementias

  5. Neuropathology Protein Degeneration (Cummings, 2003) • Abnormalities in the metabolism of three proteins account for more than 90% of all neurodegenerative dementias • misfolded proteins that cannot be properly degraded within affected cells • Amyloid-beta, alpha-synuclein, and tau • Binding along the membrane • Accumulation of these proteins • Abnormal cellular maintenance Dementias

  6. Protein Degeneration • All of these proteins are involved with maintaining the structure and integrity of neurons • Amyloid-beta: regulation of synaptic strength • Alpha-synuclein: integrity of vesicles containing neurotransmitter • DA neurons may be selectively vulnerable to toxic effects • Tau: microtubule assembly and stabilization • Dysregulation contributes to cell death Dementias

  7. Protein Degeneration • Accumulation of these proteins often begins in brainstem (substantia nigra, locus coeruleus) • Work their way to limbic and (frontal, temporal) cortical areas • Producing characteristic cell death and subsequent affects and memory and executive functioning. Dementias

  8. Protein Degeneration www.alzheimer.ca Dementias

  9. Neuropathology A. Frontal lobe dysfunction/dementias • Degeneration of neurons in the frontal lobe, basal ganglia • Interruption of frontal-subcortical pathways • Deficits similar to those of frontal lobe lesion patients. Dementias

  10. Neuropathology Symptoms of dementia (DSM-IV) • Aphasia (language disturbance). • Apraxia (impaired ability to carry out motor activities despite intact motor function).

 • Agnosia (failure to recognize or identify objects despite intact sensory function).

 Dementias

  11. Neuropathology Symptoms of dementia (DSM-IV) 4. Executive functioning • Planning, organizing, sequencing, abstracting • Working memory • Encoding new memories • Episodic memories 5. Delusions or hallucinations Dementias

  12. Neuropathology • Mood disturbances • Major depressive disorder common • Correlated to executive functioning deficits, implying further frontal lobe effects • Evidence that the severity of executive and mood disorders directly related to the volume of cortex destroyed Dementias

  13. Parkinson’s Disease • Assessment by a neuropsychologist is always undertaken in these cases • assessment of recall and recognition memory • assessment of long term memories • short-term memory • cued versus uncued recall • word naming for language function • testing for apraxia • visuospatial functioning • executive functioning Dementias

  14. Parkinson’s Disease Cognitive Deficits • Disorders of executive function: generating, maintaining, shifting, and blending of sets characterize executive-function disorders, (mental inflexibility) • decreased generation and maintenance of sets and slowness in shifting sets in new situations. • no impairment when performing overlearned tasks • benefit from external cues and structure. • difficulty with novel stimuli. Dementias

  15. Parkinson’s Disease Cognitive Deficits 2. Visuospatial difficulties: line orientation, block design, and picture arrangement, non–familiar-face discrimination (IQ subtests). • present even when motor impairment is absent. Dementias

  16. Parkinson’s Disease Cognitive Deficits 3. Memory deficits: retrieval deficits in immediate- and long-term memory impairment, abnormalities in procedural memory, (includes anterograde and retrograde amnesias) • Providing patients with retrieval cues can improve memory performance • Disproportionately impaired in their ability to temporally order or sequence new information Dementias

  17. Parkinson’s Disease Cognitive Deficits • Language abnormalities: naming and fluency, comprehending syntactically embedded questions. Their sentences tend to be grammatically simple. Deficits in speech production. 5. Full blown dementia: Disturbance in executive function is the most common; apraxia and agnosia rarely occur. Dementias

  18. Parkinson’s Disease • A neuropsychiatrist need only be involved when: • risk-taking behaviours increase as disease progresses. • violent behaviour • disinhibited behaviours • delusions of persecution • hallucinations • exaggerated responses to stress Dementias

  19. Alzheimer’s Dementia • Confirmed only though postmortem studies • Poor relation between neurobiological changes and clinical symptoms • Diagnosis is based on the general symptoms of dementia, not on imaging data. • Scale of Behavioural Change used to determine stages (Reisburg, 1983) • From Very Mild to Very Severe Dementias

  20. Alzheimer’s Dementia Dementias

  21. Alzheimer’s Dementia Dementias

  22. Alzheimer’s Neuropathology • Still mainly confirmed through postmortem findings (Selkoe, 1992; Brun, 1983) • neuropathology non-specific to Alzheimer’s • Neuritic plaques - found in cerebral cortex, and correlated with degree of cognitive dysfunction (amyloid-beta peptide) • Neurofibrillary tangles in the neurons, especially hippocampus (helical fragments) • Loss of cortical volume typically in temporal areas, limbic cortex, posterior parietal areas. Dementias

  23. Alzheimer’s Neurobiology • Loss of cells in entorhinal cortex (main input into the hippocampus) • Loss of dendrites • General decrease in neurotransmitters: NA, DA, 5HT, glutamate • Similar findings have been suggested for other types of dementias Dementias

  24. Lewy Bodies Dementia • Neurodegenerative disorder associated with abnormal structures (Lewy bodies) found in certain areas of the brain. • Associated with Parkinson's and Alzheimer's diseases • Researchers not sure whether it’s a distinct clinical entity or a variant of Alzheimer's or Parkinson's disease. • Quite common: 10-25% of all dementia cases Dementias

  25. Lewy Bodies Dementia • Appear as toxic dark red or brown spots in the cytoplasm of the neuron, typically in substantia nigra. • DA neurons may be selectively vulnerable to toxic effects • Contain the protein alpha-synuclein, which normally maintains integrity of vesicles containing neurotransmitter Dementias

  26. Other Information • Generally speaking, the severity of neuropsychological dysfunction (dementia and mood) is correlated to the extent of brain atrophy • More related to brain volume than to effects on a particular brain area. • The cause of neurodegenerative disorders is unknown • Still some debate as to whether Alzheimer’s is a disease at all Dementias

  27. Other Information • Typically dementias are not reversible but follow a progressive or static course • Reversible only if caused by a treatable general medical condition (e.g. hypoglycemia) • Ultimately, dementias lead to death (related to mobility) • increased incidence of accidents • increased susceptibility to infections Dementias

  28. The problem of treatment • Antiparkinsonian (DA) medication may actually worsen such symptoms as hallucinations and delusions. • Neuroleptic (antipsychotic) drugs prescribed for psychiatric symptoms may markedly worsen the movement symptoms (DA antagonist, among other things). • Which symptoms to treat, or can both movement and psychiatric conditions be addressed? Dementias

More Related